A NAD+ 1000mg & Retatrutide: A UK Innovation in Cellular Health
Emerging data from the UK are generating considerable excitement surrounding the potential synergy of high-dose NAD+ supplementation (1000mg) and the novel GLP-1 receptor agonist, Retatrutide. This intriguing approach aims to target multiple facets of metabolic dysfunction , potentially offering